As a strategy to evade immune responses and impair T cell response, PD-L1 is often up-regulated on tumor cells and induces T cell anergy, exhaustion, or apoptosis upon engagement with PD-1 expressed on tumor infiltrating lymphocytes (TILs) 1, 5. The gene discussed is CD274; the disease is neoplasm.